Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - TAX PROVISION
Tax Provision NBIX - Neurocrine Biosciences, Inc.
145 M
LAST VALUE
56.08%
2 YEAR CAGR
72.40%
5 YEAR CAGR
41.83%
10 YEAR CAGR